CCG Wealth Management LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,490 shares of the healthcare conglomerate’s stock, valued at approximately $760,000.
A number of other institutional investors also recently made changes to their positions in the business. Outfitter Financial LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $25,000. Blue Bell Private Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $29,000. Advocacy Wealth Management Services LLC increased its stake in shares of UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 25 shares during the period. Cascade Investment Advisors Inc. increased its stake in shares of UnitedHealth Group by 100.0% during the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 30 shares during the period. Finally, Tortoise Investment Management LLC increased its stake in shares of UnitedHealth Group by 54.8% during the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 23 shares during the period. 87.48% of the stock is currently owned by institutional investors and hedge funds.
UNH has been the topic of several recent research reports. Cowen upped their price target on UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Barclays upped their price target on UnitedHealth Group from $495.00 to $565.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 30th. Royal Bank of Canada set a $563.00 price target on UnitedHealth Group and gave the stock an “outperform” rating in a research note on Monday, April 18th. Oppenheimer boosted their target price on UnitedHealth Group from $550.00 to $600.00 and gave the stock an “outperform” rating in a report on Monday, April 18th. Finally, Raymond James boosted their target price on UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a report on Tuesday, April 19th. Three analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $555.73.
NYSE:UNH opened at $489.68 on Thursday. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.54. UnitedHealth Group Incorporated has a 12 month low of $383.12 and a 12 month high of $553.29. The company has a market cap of $459.40 billion, a PE ratio of 26.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.83. The company has a 50 day simple moving average of $496.56 and a two-hundred day simple moving average of $490.86.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, topping analysts’ consensus estimates of $5.40 by $0.09. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The business had revenue of $80.15 billion during the quarter, compared to the consensus estimate of $78.77 billion. During the same quarter in the previous year, the firm posted $5.31 EPS. The firm’s revenue was up 14.2% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th will be given a dividend of $1.65 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date is Thursday, June 16th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.35%. UnitedHealth Group’s payout ratio is presently 36.12%.
UnitedHealth Group Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.